5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

E-ISSN： 1873-4294|3|8|885-897

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.8, 2003-05, pp. : 885-897

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential use of selective 5-HT_2C agonists in treating obesity

By Smith Brian M Thomsen William J Grottick Andrew J

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

New 5-HT2C receptor agonists

By Bishop Michael J Nilsson Björn M

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1691-1705

Informa Healthcare

Access to resources Recommend Favorite

Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT 2C receptor

By Bos M. Jenck F. Martin J. Moreau J. Mutel V. Sleight A. Widmer U.

European Journal of Medicinal Chemistry, Vol. 32, Iss. 3, 1997-01 ,pp. : 253-261

Elsevier

Access to resources Recommend Favorite

5HT2C receptor agonists and antagonists in animal models of anxiety

By Martin J.R. Bouml s M. Jenck F. Kouml hler C. Moreau J.-L. Sleight A.J. Stadler H. Wichmann J.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

Effects of 5-HT 1A and 5-HT 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment

By Olausson P. Åkesson P. Engel J.A. Soderpalm B.

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 45-54

Elsevier

Access to resources Recommend Favorite